IGCS member since 2015.
I decided to pursue a career in gynecologic oncology because there was a need for a diagnostic gynecologic pathology specialist at Memorial Sloan Kettering Cancer Center. Having had rigorous training in that area during my residency, I decided to apply for that position. Superb collaborations with gynecologic and medical oncologists at our Center convinced me I had made the right decision.
I spend about 1/3 of my time in diagnostic gynecologic pathology, working one-on-one with pathology trainees and discussing results with our clinical colleagues. Most of our work derives from patients at our Center, but we also handle a good number of diagnostic second opinions. Another 1/3 of my time is spent doing collaborative gynecologic oncologic research, ranging from simple, retrospective and observational studies that bridge clinical medicine and pathology to projects involving the use of sophisticated molecular technologies. The remainder of my time is spent in departmental administration. Currently, our research focuses on risk stratification for patients with endometrial cancer, clinicopathological classification of endocervical adenocarcinoma and uterine mesenchymal tumors, the Fallopian tube’s role in ovarian carcinogenesis and genotype-phenotype-clinical correlations of heritable gynecologic cancer syndromes.